Show simple item record

dc.contributor.authorDoshi, Peter
dc.date.accessioned2018-09-24T17:55:54Z
dc.date.available2018-09-24T17:55:54Z
dc.date.issued2018-09-20
dc.identifier.citationDoshi, P. (2018). Pandemrix vaccine: why was the public not told of early warning signs? BMJ, 362:k3948. doi: 10.1136/bmj.k3948en_US
dc.identifier.urihttp://hdl.handle.net/10713/8270
dc.description.abstractEight years after the pandemic influenza outbreak, a lawsuit alleging that GlaxoSmithKline’s Pandemrix vaccine caused narcolepsy has unearthed internal reports suggesting problems with the vaccine’s safety. Peter Doshi asks what this means for the future of transparency during public health emergencies.en_US
dc.description.urihttp://bmj.com/cgi/content/full/bmj.k3948?ijkey=Q078zFNInyGN8CS&keytype=refen_US
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectPandemrixen_US
dc.subject.lcshGlaxoSmithKlineen_US
dc.subject.meshDisclosureen_US
dc.subject.meshDrug Evaluationen_US
dc.subject.meshImmunization Programs--ethics en_US
dc.subject.meshInfluenza Vaccines--adverse effectsen_US
dc.titlePandemrix vaccine: why was the public not told of early warning signs?en_US
dc.typeArticleen_US
dc.description.versionYesen_US
dc.identifier.pmid30237282
dc.identifier.ispublishedNoen_US
dc.description.urinameClick here for the free full-text article on publisher’s websiteen_US
refterms.dateFOA2019-02-19T17:57:34Z


Files in this item

Thumbnail
Name:
Doshi_Pandermrix2018.pdf
Size:
1.415Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/